Magnesium pyridoxal 5-phosphate glutamate

Magnesium pyridoxal 5-phosphate glutamate
Clinical data
Trade names	Sedalipid
ATC code	C10AX07 (WHO) ;
Identifiers
	IUPAC name (2S)-2,5-diamino-5-oxopentanoic acid;; (4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl dihydrogen phosphate;
CAS Number	62055-05-4 (magnesium salt);
PubChem CID	173846;
ChemSpider	151728 ;
CompTox Dashboard (EPA)	DTXSID00977622 ;
Chemical and physical data
Formula	C13H20N3O9P
Molar mass	393.289 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(N)CC[C@H](N)C(=O)O.O=P(O)(O)OCc1cnc(c(O)c1C=O)C;
	InChI InChI=1S/C8H10NO6P.C5H10N2O3/c1-5-8(11)7(3-10)6(2-9-5)4-15-16(12,13)14;6-3(5(9)10)1-2-4(7)8/h2-3,11H,4H2,1H3,(H2,12,13,14);3H,1-2,6H2,(H2,7,8)(H,9,10)/t;3-/m.0/s1 ; Key:BCARVEADLDZBJT-HVDRVSQOSA-N ;
	(verify)

Magnesium pyridoxal 5-phosphate glutamate (trade name Sedalipid) is a hypolipidemic agent.^[1]

References

^ Schuitemaker GE, van der Pol GA, Aretz CP, Dinant GJ (2001). "A placebo-controlled, double-blind, randomised trial of magnesium-pyridoxal-5'-phosphate-glutamate for hypercholesterolaemia and other clinical-chemical risk factors of cardiovascular disease in a primary care setting". Eur. J. Clin. Pharmacol. 56 (12): 857–63. doi:10.1007/s002280000247. PMID 11317472.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.